Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.
[Current immunotherapy of multiple sclerosis].
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis.
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography.
Y-39983, a Selective Rho-Kinase Inhibitor, Attenuates Experimental Autoimmune Encephalomyelitis via Inhibition of Demyelination.
Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: Biochemical, pharmacological and toxicological implications.
Unilateral ankle dorsiflexor spasticity: an uncommon, disabling complication of transverse myelitis.
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.
Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
Prognostic factors of acute partial transverse myelitis.
MRI criteria distinguishing seropositive NMO spectrum disorder from MS.
Couples coping with multiple sclerosis: a dyadic perspective on the roles of mindfulness and acceptance.
Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions.
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation.
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
Relapsing-Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells.
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer.
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
Pages
« first
‹ previous
…
204
205
206
207
208
209
210
211
212
…
next ›
last »